← Back to headlines
Medtronic's Cardiovascular and Diabetes Segments Show Strong Growth in FQ3
Medtronic's cardiovascular and diabetes divisions posted mid-teens growth in the third fiscal quarter, indicating strong performance in these key areas.
17 Feb, 12:15 — 17 Feb, 12:15
ℹOnly 1 source covers this story
